Correlation Between Cuprina Holdings and Processa Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Cuprina Holdings and Processa Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cuprina Holdings and Processa Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cuprina Holdings Limited and Processa Pharmaceuticals, you can compare the effects of market volatilities on Cuprina Holdings and Processa Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cuprina Holdings with a short position of Processa Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cuprina Holdings and Processa Pharmaceuticals.

Diversification Opportunities for Cuprina Holdings and Processa Pharmaceuticals

0.75

Correlation Coefficient

Cuprina Holdings  Processa Pharmaceuticals

Poor diversification

The 3 months correlation between Cuprina and Processa is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Cuprina Holdings Limited and Processa Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Processa Pharmaceuticals and Cuprina Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cuprina Holdings Limited are associated (or correlated) with Processa Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Processa Pharmaceuticals has no effect on the direction of Cuprina Holdings i.e., Cuprina Holdings and Processa Pharmaceuticals go up and down completely randomly.

Pair Corralation between Cuprina Holdings and Processa Pharmaceuticals

Given the investment horizon of 90 days Cuprina Holdings Limited is expected to under-perform the Processa Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Cuprina Holdings Limited is 4.48 times less risky than Processa Pharmaceuticals. The stock trades about -0.23 of its potential returns per unit of risk. The Processa Pharmaceuticals is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  710.00  in Processa Pharmaceuticals on October 8, 2025 and sell it today you would lose (387.00) from holding Processa Pharmaceuticals or give up 54.51% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Cuprina Holdings Limited  vs.  Processa Pharmaceuticals

Cuprina Holdings

Risk-Adjusted Performance

Weakest

Over the last 90 days Cuprina Holdings Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Even with uncertain performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in February 2026. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Processa Pharmaceuticals

Risk-Adjusted Performance

Weakest

Over the last 90 days Processa Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2026. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Cuprina Holdings and Processa Pharmaceuticals

The main advantage of trading using opposite Cuprina Holdings and Processa Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cuprina Holdings position performs unexpectedly, Processa Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Processa Pharmaceuticals will offset losses from the drop in Processa Pharmaceuticals' long position.

The idea behind Cuprina Holdings Limited and Processa Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.